News-posts

News Post

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

TechTrends / , , / /

SOMERSET, N.J., July 26, 2024 — Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced preliminary, unaudited financial results for the six-months ended June 30, 2024. For the six-months ended June 30, 2024, Legend Biotech expects to record an adjusted net loss for the period of approximately $94.7 million […]

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024 Read More »

Xsolla Expands Support in the Greater China Region

Xsolla Expands Support in the Greater China Region

BizTech / , , , / /

Xsolla, a global video game commerce company known for its extensive suite of tools and services specifically designed for the game industry, is thrilled to announce the grand opening of the Xsolla Greater China Region office. The opening event will occur on Monday, July 22, 2024, at D-06 Parkview Green Fangcaodi, Chaoyang District, signifying a

Xsolla Expands Support in the Greater China Region Read More »

CHMP has adopted a negative opinion on lecanemab for the EU

CHMP has adopted a negative opinion on lecanemab for the EU

HealthTech / /

STOCKHOLM, July 26, 2024 — The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has today communicated that it has adopted a negative opinion on BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai’s Marketing Authorization Approval (MAA) for lecanemab as treatment for Alzheimer’s disease. BioArctic is currently consulting

CHMP has adopted a negative opinion on lecanemab for the EU Read More »

Revolo's Data Shows Benefits of '1104 and Subcutaneous Delivery

Revolo Announces New Data Further Validating the Upstream Mechanism of Action and Subcutaneous Administration of ‘1104

InfoTech / , , , / /

Reduction of key proteins in the interleukin 4 (IL-4) and IL-13 signalling pathway via SHP-1 activation is a key component involved in the mechanism of action of ‘1104 First-in-class upstream approach uniquely affects both the effector and regulatory arms of the immune response, helping to restore immune homeostasis Compelling subcutaneous data verifies the continued advancement

Revolo Announces New Data Further Validating the Upstream Mechanism of Action and Subcutaneous Administration of ‘1104 Read More »

Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of its AI-Driven DeepView System

TechTrends / , , / /

DALLAS, July 24, 2024 — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a 30% increase in its patent portfolio that strengthens and protects its proprietary, AI-driven DeepView System wound assessment platform.

Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of its AI-Driven DeepView System Read More »

Babel Cover announces the launch of autonomous digital motorcycle insurance service

FinTech / /

LONDON, July 23, 2024 — Babel Cover, a British financial engineering and insurance technology start-up, enters the motorcycle sector with an autonomous set of applications following a robust process of technology stability and scaling tests over the past nine months. It has partnered with Poe-ma Insurances (“Poe-ma”) a Parisian headquartered independent insurance agency active for over

Babel Cover announces the launch of autonomous digital motorcycle insurance service Read More »

Provident Healthcare Partners Wins Two Awards at the 6th Annual USA M&A Atlas Awards

Provident Healthcare Partners Wins Two Awards at the 6th Annual USA M&A Atlas Awards

TechTrends / /

BOSTON and NEW YORK, July 19, 2024 — Provident Healthcare Partners (“Provident”) was the recipient of two awards at the 6th Annual USA M&A Atlas Awards, which took place on June 24, 2024 at the Metropolitan Club in New York City. Provident won in the category of Private Equity Add-on Deal of the Year (Lower Mid-Markets) for

Read More »

Brown & Brown, Inc. included on 2024 Fortune Best Workplaces for Millennials™ list

BizTech / , / /

DAYTONA BEACH, Fla., July 18, 2024 — J. Powell Brown, president and chief executive officer, and Julie Turpin, chief people officer, are pleased to announce that Great Place To Work® and Fortune Magazine have named Brown & Brown, Inc. as one of the 2024 Best Workplaces for Millennials. Chief People Officer Julie Turpin shares, “We value the

Read More »

Kolmar Korea Appoints Global Experts to Speed up Its Presence in North America

Kolmar Korea Appoints Global Experts to Speed up Its Presence in North America

BizTech / , / /

Kolmar Korea (KRX: 161890) is speeding up its global expansion by appointing experts in the global cosmetics industry to its North American subsidiary. With the plan to build its second U.S. plant early next year, the company has appointed a new head for its North American operations and a Global Chief Commercial Officer (GCCO). It

Kolmar Korea Appoints Global Experts to Speed up Its Presence in North America Read More »

American National Introduces Proprietary Custom Annuity Index

American National Introduces Proprietary Custom Annuity Index

BizTech / , , / /

HOUSTON, — American National Group (“American National”) today announced the launch of its first proprietary custom index, which will be paired with American National’s Strategy Index 10 annuity. Developed in collaboration with BNP Paribas, the Patriot Technology Index is designed to offer clients a unique blend of innovation, protection, and growth potential. The Strategy Index

American National Introduces Proprietary Custom Annuity Index Read More »

Scroll to Top